These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38955994)

  • 1. ASO Author Reflections: Distilling Wisdom From Two Decades of Cutaneous Malignant Melanoma at a Peruvian Cancer Institute: A Stirring Call for Action.
    Ziegler-Rodriguez G; Ziegler-Rodriguez O; De La Cruz-Ku G; Cotrina-Concha JM; Dunstan J; Pinillos-Portella M; Vilchez-Santillan S; Möller MG
    Ann Surg Oncol; 2024 Jul; ():. PubMed ID: 38955994
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Hematological Biomarkers of Survival in Cutaneous Melanoma.
    Robinson AV; Peach H; Wade RG
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):910-911. PubMed ID: 30324481
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Cutaneous Melanoma as Model System for the Obesity Paradox in Cancer.
    Harrell Shreckengost C; Lowe MC
    Ann Surg Oncol; 2021 Oct; 28(11):6152-6153. PubMed ID: 33748893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASO Author Reflections: Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas.
    Thompson JF; Scolyer RA; Lo SN
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):918-919. PubMed ID: 30414034
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Management of the Lymph Node Basin in Cutaneous Melanoma-Patterns of Completion Dissection in a National Cohort.
    Sharon CE; Karakousis GC; Miura JT
    Ann Surg Oncol; 2022 Dec; 29(13):8465-8466. PubMed ID: 35933534
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Effectiveness of SPECT/CT Imaging for Sentinel Node Biopsy Staging of Primary Cutaneous Melanoma and Patient Outcomes.
    Moncrieff M; Pywell S; Snelling A; Gray M; Newman D; Beadsmoore C; Heaton M; Pawaroo D
    Ann Surg Oncol; 2022 Feb; 29(2):776-777. PubMed ID: 34845566
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Comparison of Indocyanine Green with Blue Dye in Sentinel Lymph Node Biopsy for Cutaneous Melanoma.
    Fadel MG; Smith MJ
    Ann Surg Oncol; 2023 Jul; 30(7):4341-4342. PubMed ID: 37014554
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Racial Disparities in Time to Breast Cancer Treatment-A Call to Action.
    Bayard S; Bea VJ
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):599. PubMed ID: 35902498
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Improved Perioperative Seroma and Complication Rates Following the Application of a Two-Layer Negative Pressure Wound Therapy System After Inguinal Lymphadenectomy for Metastatic Cutaneous Melanoma.
    Moncrieff M; Heaton M
    Ann Surg Oncol; 2020 Oct; 27(10):3702-3703. PubMed ID: 32462528
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Counseling Melanoma Survivors on the Risk of a Second Melanoma.
    Wiener AA; Schumacher JR; Neuman HB
    Ann Surg Oncol; 2022 Sep; 29(9):5933-5934. PubMed ID: 35524082
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB-IIC Patients After 3 Years.
    Moncrieff M; Underwood B; Garioch J; Heaton M; Patel N; Bastiaannet E; Hoekstra-Weebers J; Hoekstra H
    Ann Surg Oncol; 2020 Oct; 27(11):4120-4121. PubMed ID: 32651698
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Closing the Gap: A Call to Action to Improve Access and Outcomes of Peritoneal Surface Malignancy Care.
    Winicki NM; Johnston FM; Greer JB
    Ann Surg Oncol; 2023 Nov; 30(12):7863-7864. PubMed ID: 37620536
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Delays in Breast Cancer Treatment During the COVID Pandemic-Disparities in Delay and a Call to Action.
    Chung SH; Sachs TE
    Ann Surg Oncol; 2023 Oct; 30(10):6106-6107. PubMed ID: 37434072
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Melanoma Killed Bob Marley and Others Too.
    Asare EA; Stewart JH
    Ann Surg Oncol; 2021 Nov; 28(12):6994. PubMed ID: 34176059
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Is There a Relationship Between TIL and Regression in Melanoma?
    Morrison S; Zager JS; Vetto J
    Ann Surg Oncol; 2022 May; 29(5):2867-2868. PubMed ID: 35059884
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Why Treatment Risk Thresholds Are Needed for Patients with Melanoma.
    Bartlett EK; Marchetti MA
    Ann Surg Oncol; 2022 Sep; 29(9):5957-5958. PubMed ID: 35524083
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Staging System for Mucosal Melanoma: A Proposal to Fill a Gap.
    Cui C; Lian B; Guo J
    Ann Surg Oncol; 2022 Aug; 29(8):5235-5236. PubMed ID: 35412206
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Treatment Approaches to Sinonasal Mucosal Melanoma.
    Amit M; Hanna EY
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):890-891. PubMed ID: 30267288
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Effects of the Updated AJCC Classification for Patients with Stage III Melanoma.
    Katsarelias D; Isaksson K; Olofsson Bagge R
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):713-714. PubMed ID: 31468215
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Metastatic Melanoma to the Large Bowel.
    Young CJ
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):675-676. PubMed ID: 30406486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.